Evaluation of Microscopic Tumour Extension in Localized Stage Non-Small-Cell Lung Cancer for Stereotactic Radiotherapy Planning.
Fiche publication
Date publication
mars 2022
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Dr LINDNER Véronique, Pr NOEL Georges
Tous les auteurs :
Schmitt M, Aussenac L, Seitlinger J, Lindner V, Noël G, Antoni D
Lien Pubmed
Résumé
Stereotactic radiotherapy for localised stage non-small-cell lung carcinoma (NSCLC) is an alternative indication for patients who are inoperable or refuse surgery. A study showed that the microscopic tumour extension (ME) of NSCLC varied according to the histological type, which allowed us to deduce adapted margins for the clinical target volume (CTV). However, to date, no study has been able to define the most relevant margins for patients with stage 1 tumours.
Mots clés
adenocarcinoma, non-small-cell lung carcinoma, squamous cell carcinoma, stereotactic body radiation therapy
Référence
Cancers (Basel). 2022 Mar 2;14(5):